Phase 2 Study Results from a Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate Efficacy and Safety of Tigulixostat, a Novel Non-purine Selective Xanthine Oxidase Inhibitor, in Gout Patients with Hyperuricemia

Showing live article 632 of 1272 in channel 80318369
Article Details:

Author:
Language: English
Channel Number: 80318369
Article Number: 632
Date: October 19, 2021, 9:00 am
URL: https://acrabstracts.org/abstract/phase-2-study-results-from-a-randomized-double-blind-placebo-controlled-dose-finding-study-to-evaluate-efficacy-and-safety-of-tigulixostat-a-novel-non-purine-selective-xanthine-oxidase-inhibitor/
GUID: https://acrabstracts.org/abstract/phase-2-study-results-from-a-randomized-double-blind-placebo-controlled-dose-finding-study-to-evaluate-efficacy-and-safety-of-tigulixostat-a-novel-non-purine-selective-xanthine-oxidase-inhibitor/